Pharma-Bio Serv (PBSV) Gains from Investment Securities (2010 - 2025)
Pharma-Bio Serv (PBSV) reported Gains from Investment Securities of -$528746.0 for Q4 2025, up 20.04% on a YoY basis from -$440492.2 in Q4 2024, and down 200.0% quarter-over-quarter from $528746.0 in Q2 2025.
Pharma-Bio Serv (PBSV) Gains from Investment Securities (2010 - 2025) Analysis & Trends
Pharma-Bio Serv has reported Gains from Investment Securities for 15 years, with the latest figure at -$528746.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities rose 20.04% year-over-year to -$528746.0; the trailing twelve-month figure through Oct 2025 stood at -$661224.0 (changed N/A YoY), and the FY2025 full-year result was $453350.0, up 403.72% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at -$528746.0, down from $528746.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $528746.0 in Q2 2025, with the low at -$661224.0 in Q4 2024.
- Historically, Gains from Investment Securities has averaged $164168.8 across 5 years, with a median of $384816.5 in 2023.
- Annual changes were most pronounced in 2024 — Gains from Investment Securities plunged 292.58% — and 2025, when it climbed 24.04%.
- Pharma-Bio Serv's Gains from Investment Securities stood at $470000.0 in 2021, then grew by 6.38% to $500000.0 in 2022, then slumped by 31.33% to $343350.0 in 2023, then sank by 292.58% to -$661224.0 in 2024, then increased by 20.04% to -$528746.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$528746.0 (Q4 2025), $528746.0 (Q2 2025), and -$661224.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -528,746.00 |
| Oct 31, 2025 | -528,746.00 |
| Apr 30, 2025 | 528,746.00 |
| Apr 30, 2025 | 528,746.00 |
| Oct 31, 2024 | -661,224.00 |
| Oct 31, 2024 | -661,224.00 |
| Jul 31, 2024 | 234,941.00 |
| Jul 31, 2024 | 234,941.00 |
| Apr 30, 2024 | 426,283.00 |
| Apr 30, 2024 | 426,283.00 |
| Oct 31, 2023 | 343,350.00 |
| Oct 31, 2023 | 343,350.00 |
| Oct 31, 2022 | 500,000.00 |
| Oct 31, 2022 | 500,000.00 |
| Oct 31, 2021 | 470,000.00 |
| Oct 31, 2021 | 470,000.00 |
| Apr 30, 2020 | 24,995.00 |
| Apr 30, 2020 | 24,995.00 |
| Oct 31, 2019 | 133,944.00 |
| Oct 31, 2019 | 133,944.00 |